Los Angeles Times – Additional coverage on a study by researchers from the Dartmouth Institute for Health Policy and Clinical Practice at Geisel and Harvard, which found that mammogram screening tests aren’t working as hoped. Instead of preventing deaths by uncovering breast tumors at an early, more curable stage, screening mammograms have mainly found small tumors that would have been harmless if left alone.
Post Tagged with: "cancer"
The Post and Courier – Cites a recent Geisel School of Medicine study, which surveyed 1,050 young smokers, age 15-23, and found that within two years, 39 percent who had smoked a hookah had graduated to cigarettes. The study notes that the young and impressionable get hooked at a more than 30 percent rate.
Chemical & Engineering News – References comments made by David Roberts, professor of surgery and neurology, on a new optical coherence tomography (OCT) device that surgeons could potentially use to help remove tumors from the brain.
Seattle Times – Quotes David Roberts, professor of surgery and neurology, on news that Seattle Children’s Hospital will be testing a new dye derived from scorpion venom that lights up cancer cells so surgeons can see — and remove — deadly brain tumors. Roberts and other colleagues have also been testing a similar drug compound, 5-aminolevulinic acid (5-ALA), which targets glial tumors.
The Guardian – This article mentions Dartmouth’s Geisel School of Medicine in an article about the overall impact of a cancer immunotherapy clinical trial on melanoma patients, and that the two drugs used in the trial, ipilimumab and nivolumab, were created by the biotech firm called Medarex founded by immunologists from Geisel.
Gazette Review – A new study coming out of Dartmouth is showing that television food commercials are stimulating the brains of overweight teenagers more than any other group of people.
A new randomized clinical trial with Dartmouth investigators has noted significant improvement in several measures among those who began palliative care early.
In this Q&A, TDI demographer Samir Soneji, PhD discusses how demographers are able to predict how changes in population affect public policy by forecasting future disease and mortality rates.
A neuro-oncology research team at Dartmouth’s Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of tumor cell invasion in glioblastoma.
The National Cancer Institute (NCI) has renewed its Cancer Center Support Grant to Norris Cotton Cancer Center (NCCC) at Dartmouth, continuing NCCC’s designation as a Comprehensive Cancer Center.